{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:06:12Z","timestamp":1783595172445,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Mallinckrodt ARD"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12882-016-0241-7","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T05:41:52Z","timestamp":1459402912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series"],"prefix":"10.1186","volume":"17","author":[{"given":"Arvind","family":"Madan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snezana","family":"Mijovic-Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Teehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber S.","family":"Milward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupa","family":"Khastgir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"241_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2:139\u2013274.","journal-title":"Kidney Int Suppl"},{"key":"241_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2013.06.002","volume":"62","author":"L Beck","year":"2013","unstructured":"Beck L, Bomback AS, Choi MJ, Holzman LB, Langford C, Mariani LH, Somers MJ, Trachtman H, Waldman M. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis. Am J Kidney Dis. 2013;62:403\u201341.","journal-title":"Am J Kidney Dis"},{"key":"241_CR3","first-page":"448","volume":"33","author":"A Segarra-Medrano","year":"2013","unstructured":"Segarra-Medrano A, Jatem-Escalante E, Agraz-Pamplona I, Carnicer-Caceres C, Ramos-Terrades N, Ostos-Roldan E, Quiles-Perez MT, Arbos-Via MA. Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors. Nefrologia. 2013;33:448\u201361.","journal-title":"Nefrologia"},{"key":"241_CR4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D\u2019Agati V, Appel G. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2:445\u201353.","journal-title":"Clin J Am Soc Nephrol"},{"key":"241_CR5","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1093\/ndt\/gfp356","volume":"24","author":"C Manno","year":"2009","unstructured":"Manno C, Torres DD, Rossini M, Pesce F, Schena FP. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant. 2009;24:3694\u2013701.","journal-title":"Nephrol Dial Transplant"},{"key":"241_CR6","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","volume":"18","author":"HN Reich","year":"2007","unstructured":"Reich HN, Troyanov S, Scholey JW, Cattran DC. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007;18:3177\u201383.","journal-title":"J Am Soc Nephrol"},{"key":"241_CR7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","volume":"64","author":"BH Hahn","year":"2012","unstructured":"Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64:797\u2013808.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"241_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.2009.412","volume":"77","author":"J Radhakrishnan","year":"2010","unstructured":"Radhakrishnan J, Moutzouris DA, Ginzler EM, Solomons N, Siempos II, Appel GB. Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. Kidney Int. 2010;77:152\u201360.","journal-title":"Kidney Int"},{"key":"241_CR9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ncpneph0915","volume":"4","author":"D Philibert","year":"2008","unstructured":"Philibert D, Cattran D. Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price? Nat Clin Pract Nephrol. 2008;4:550\u20139.","journal-title":"Nat Clin Pract Nephrol"},{"key":"241_CR10","unstructured":"H.P. Acthar\u00ae Gel (repository corticotropin injection) [prescribing information]. Hazelwood: Mallinckrodt ARD Inc.; 2015."},{"key":"241_CR11","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.1951.03670290009004","volume":"147","author":"M Rapoport","year":"1951","unstructured":"Rapoport M, McCrory WW, Barbero G, Barnett HL, Forman CW. Effect of corticotropin (ACTH) on children with the nephrotic syndrome. JAMA. 1951;147:1101\u20136.","journal-title":"JAMA"},{"key":"241_CR12","first-page":"225","volume":"185","author":"P Durand","year":"1955","unstructured":"Durand P, DeToni Jr E. Treatment of nephrotic syndrome in children. An Paediatr. 1955;185:225\u201335.","journal-title":"An Paediatr"},{"key":"241_CR13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ackd.2013.09.004","volume":"21","author":"R Gong","year":"2014","unstructured":"Gong R. Leveraging melanocortin pathways to treat glomerular diseases. Adv Chronic Kidney Dis. 2014;21:134\u201351.","journal-title":"Adv Chronic Kidney Dis"},{"key":"241_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/DDDT.S17521","volume":"5","author":"AS Bomback","year":"2011","unstructured":"Bomback AS, Tumlin JA, Baranski J, Bourdeau JE, Besarab A, Appel AS, Radhakrishnan J, Appel GB. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel. Drug Des Devel Ther. 2011;5:147\u201353.","journal-title":"Drug Des Devel Ther"},{"key":"241_CR15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000339287","volume":"36","author":"AS Bomback","year":"2012","unstructured":"Bomback AS, Canetta PA, Beck Jr LH, Ayalon R, Radhakrishnan J, Appel GB. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial. Am J Nephrol. 2012;36:58\u201367.","journal-title":"Am J Nephrol"},{"key":"241_CR16","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2215\/CJN.02840313","volume":"8","author":"J Hogan","year":"2013","unstructured":"Hogan J, Bomback AS, Mehta K, Canetta PA, Rao MK, Appel GB, Radhakrishnan J, Lafayette RA. Treatment of idiopathic FSGS with adrenocorticotropic hormone gel. Clin J Am Soc Nephrol. 2013;8:2072\u201381.","journal-title":"Clin J Am Soc Nephrol"},{"key":"241_CR17","doi-asserted-by":"crossref","first-page":"489869","DOI":"10.1155\/2013\/489869","volume":"2013","author":"JA Tumlin","year":"2013","unstructured":"Tumlin JA, Galphin CM, Rovin BH. Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1. J Diabetes Res. 2013;2013:489869.","journal-title":"J Diabetes Res"},{"key":"241_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/IJNRD.S50660","volume":"6","author":"MJ Watson","year":"2013","unstructured":"Watson MJ. Membranous glomerulopathy and treatment with Acthar\u00ae: a case study. Int J Nephrol Renovasc Dis. 2013;6:229\u201332.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"241_CR19","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/ndt\/gfu069","volume":"29","author":"MA Hladunewich","year":"2014","unstructured":"Hladunewich MA, Cattran D, Beck LH, Odutayo A, Sethi S, Ayalon R, Leung N, Reich H, Fervenza FC. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar\u00ae Gel) in nephrotic syndrome due to idiopathic membranous nephropathy. Nephrol Dial Transplant. 2014;29:1570\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"241_CR20","doi-asserted-by":"crossref","unstructured":"Lieberman KV, Ettinger L, Picarelli C: Adrenocorticotropic hormone for steroid-resistant and oral steroid-intolerant children with minimal change nephrotic syndrome. J Clin Pediatr Nephrol 2014, 2: http:\/\/www.jpnephrology.com\/index.php\/FIRST\/article\/view\/64 .","DOI":"10.15401\/jcpn\/2014\/v2i2\/66332"},{"key":"241_CR21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1681\/ASN.2004070593","volume":"16","author":"S Troyanov","year":"2005","unstructured":"Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol. 2005;16:1061\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"241_CR22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1523-1755.2004.00873.x","volume":"66","author":"S Troyanov","year":"2004","unstructured":"Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC. Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int. 2004;66:1199\u2013205.","journal-title":"Kidney Int"},{"key":"241_CR23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrneph.2013.125","volume":"9","author":"JM Hofstra","year":"2013","unstructured":"Hofstra JM, Fervenza FC, Wetzels JF. Treatment of idiopathic membranous nephropathy. Nat Rev Nephrol. 2013;9:443\u201358.","journal-title":"Nat Rev Nephrol"},{"key":"241_CR24","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1681\/ASN.2009101025","volume":"21","author":"A Lindskog","year":"2010","unstructured":"Lindskog A, Ebefors K, Johansson ME, Stefansson B, Granqvist A, Arnadottir M, Berg AL, Nystrom J, Haraldsson B. Melanocortin 1 receptor agonists reduce proteinuria. J Am Soc Nephrol. 2010;21:1290\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"241_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrneph.2011.190","volume":"8","author":"R Gong","year":"2012","unstructured":"Gong R. The renaissance of corticotropin therapy in proteinuric nephropathies. Nat Rev Nephrol. 2012;8:122\u20138.","journal-title":"Nat Rev Nephrol"},{"issue":"suppl","key":"241_CR26","first-page":"136A","volume":"22","author":"R Gong","year":"2011","unstructured":"Gong R, Dworkin LD. Adrenocorticotropin (ACTH) gel suppresses renal tubulointerstitial inflammation and injury by direct stimulation of the melanocortin 1 receptor (MC1R) [abstract]. J Am Soc Nephrol. 2011;22(suppl):136A.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-016-0241-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T03:57:30Z","timestamp":1567742250000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-016-0241-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1186\/s12882-016-0241-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]},"article-number":"37"}}